1 terminated. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
Follow Stage III Uterine Sarcoma: new trials by email Literature Review of Stage III Uterine Sarcoma trials Research Report on Stage III Uterine Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer EF5, motexafin lutetium, pharmacological study - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Not applicable | Terminated | National Cancer Institute (NCI) | 30 | 2004-05-01 | 2013-01-16 |
Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Colonic Neoplasms (1) · Fallopian Tube Neoplasms (1) · Gallbladder Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Pancreatic Neoplasms (1) · Rectal Neoplasms (1) · Sarcoma (1) · Stomach Neoplasms (1)
Adenocarcinoma (1) · Adnexal Diseases (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Biliary Tract Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Cecal Diseases (1) · Cecal Neoplasms (1) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1)
National Cancer Institute (NCI) (1)
United States (1)
P01CA087971 (1)